glp 1 oral meds Pills vs. Pens: The Ultimate Comparison of and Injectable GLP-1s The GLP -1 Revolution Goes
Description
These findings led to a suggested role for GIP in the development of obesity, highlighting the therapeutic opportunity of GIP receptor antagonism, and subsequently leading to great interest and research activity within the field (53)
Tirzepatide (Mounjaro, Zepbound) Tirzepatide is a dual GIP/GLP-1 agonist, meaning it acts on two receptors instead of one
References: American Diabetes Association
& Jha, P
The unit-to-mg conversion principle is universal, but typical concentrations differ significantly between peptides
Under 18s : While some limited paediatric licenses exist (such as Saxenda for ages 12+), most GLP-1s are not for minors
